Venus Concept (NASDAQ:VERO – Get Rating) is scheduled to be releasing its earnings data after the market closes on Thursday, May 12th. Analysts expect Venus Concept to post earnings of ($0.10) per share for the quarter. Venus Concept has set its FY 2022 guidance at EPS.Persons that wish to register for the company’s earnings conference call can do so using this link.
Venus Concept (NASDAQ:VERO – Get Rating) last released its quarterly earnings data on Monday, March 28th. The company reported ($0.08) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.04. The company had revenue of $32.63 million for the quarter, compared to the consensus estimate of $32.50 million. Venus Concept had a negative return on equity of 72.05% and a negative net margin of 21.79%. During the same period in the previous year, the business earned ($0.22) earnings per share. On average, analysts expect Venus Concept to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
NASDAQ VERO opened at $0.86 on Thursday. The company has a current ratio of 3.43, a quick ratio of 2.77 and a debt-to-equity ratio of 1.86. The stock’s 50 day moving average is $1.32 and its two-hundred day moving average is $1.53. The company has a market capitalization of $55.17 million, a price-to-earnings ratio of -2.05 and a beta of 2.28. Venus Concept has a 1-year low of $0.75 and a 1-year high of $3.37.
Separately, Zacks Investment Research downgraded Venus Concept from a “buy” rating to a “hold” rating in a report on Tuesday, March 22nd.
About Venus Concept (Get Rating)
Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
- Get a free copy of the StockNews.com research report on Venus Concept (VERO)
- Limelight Networks Stock is a Speculative Turnaround Opportunity
- The Selloff In SiteOne Landscape Supply Is Overextended
- Camping World Confirms Support At Institutional Bottom
- What’s Next For Starbucks (NASDAQ: SBUX)?
- 3 Earnings Plays With Big Move Potential
Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.